89 related articles for article (PubMed ID: 12428087)
1. Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus.
Krishnaswami A; Carr ME; Jesse RL; Kontos MC; Minisi AJ; Ornato JP; Vetrovec GW; Martin EJ
Thromb Haemost; 2002 Nov; 88(5):739-44. PubMed ID: 12428087
[TBL] [Abstract][Full Text] [Related]
2. Platelet contractile force (PCF) and clot elastic modulus (CEM) are elevated in diabetic patients with chest pain.
Carr ME; Krishnaswami A; Martin EJ
Diabet Med; 2002 Oct; 19(10):862-6. PubMed ID: 12358876
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
Carr ME; Martin EJ; Kuhn JG; Seremetis SV
Thromb Haemost; 2003 May; 89(5):803-11. PubMed ID: 12719776
[TBL] [Abstract][Full Text] [Related]
4. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.
Carr ME; Martin EJ; Carr SL
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):193-7. PubMed ID: 11943932
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Carr ME
Haemophilia; 2007 Sep; 13(5):533-41. PubMed ID: 17880440
[TBL] [Abstract][Full Text] [Related]
6. Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME
Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
[TBL] [Abstract][Full Text] [Related]
7. Enhanced platelet force development despite drug-induced inhibition of platelet aggregation in patients with thromboangiitis obliterans--two case reports.
Carr ME; Hackney MH; Hines SJ; Heddinger SP; Carr SL; Martin EJ
Vasc Endovascular Surg; 2002; 36(6):473-80. PubMed ID: 12476239
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care determination of baseline platelet function as a predictor of clinical outcomes in patients who present to the emergency department with chest pain.
Selvaraj CL; Van De Graaff EJ; Campbell CL; Abels BS; Marshall JP; Steinhubl SR
J Thromb Thrombolysis; 2004 Oct; 18(2):109-15. PubMed ID: 15789177
[TBL] [Abstract][Full Text] [Related]
9. Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery.
Greilich PE; Brouse CF; Beckham J; Jessen ME; Martin EJ; Carr ME
Thromb Res; 2002 Mar; 105(6):523-9. PubMed ID: 12091054
[TBL] [Abstract][Full Text] [Related]
10. Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage.
Greilich PE; Carr ME; Carr SL; Chang AS
Anesth Analg; 1995 Mar; 80(3):459-65. PubMed ID: 7864408
[TBL] [Abstract][Full Text] [Related]
11. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease.
Ekmekçi H; Işler I; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
Thromb Res; 2006; 117(3):249-54. PubMed ID: 16378831
[TBL] [Abstract][Full Text] [Related]
12. Rest-Only Myocardial CT Perfusion in Acute Chest Pain.
Thomas DM; Larson CW; Cheezum MK; Villines TC; Branch KR; Blankstein R; Cury RC; Slim AM
South Med J; 2015 Nov; 108(11):688-94. PubMed ID: 26539951
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid.
Verdoia M; Schaffer A; Pergolini P; Rolla R; Barbieri L; Bellomo G; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
J Cardiovasc Pharmacol; 2015 Jul; 66(1):35-40. PubMed ID: 25714593
[TBL] [Abstract][Full Text] [Related]
14. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
16. Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies.
Carr ME; Carr SL; Tildon T; Fisher LM; Martin EJ
J Thromb Haemost; 2003 Feb; 1(2):243-9. PubMed ID: 12871496
[TBL] [Abstract][Full Text] [Related]
17. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting.
Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM
Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776
[TBL] [Abstract][Full Text] [Related]
18. The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.
Brophy DF; Martin EJ; Carr SL; Kirschbaum B; Carr ME
Thromb Res; 2007; 119(6):723-9. PubMed ID: 16793120
[TBL] [Abstract][Full Text] [Related]
19. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
20. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
Duygu H; Turkoglu C; Kirilmaz B; Turk U
J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
